Citations (60)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Raj Kumar, Keshaw Ram Aadil, Kunal Mondal, Yogendra Kumar Mishra, David Oupicky, Seeram Ramakrishna & Ajeet Kaushik. (2022) Neurodegenerative disorders management: state-of-art and prospects of nano-biotechnology. Critical Reviews in Biotechnology 42:8, pages 1180-1212.
Read now
Read now
Saikat Ghosh, Rohan Lalani, Vivek Patel, Subhas Bhowmick & Ambikanandan Misra. (2019) Surface engineered liposomal delivery of therapeutics across the blood brain barrier: recent advances, challenges and opportunities. Expert Opinion on Drug Delivery 16:12, pages 1287-1311.
Read now
Read now
Débora B Vieira & Lionel F Gamarra. (2016) Getting into the brain: liposome-based strategies for effective drug delivery across the blood–brain barrier. International Journal of Nanomedicine 11, pages 5381-5414.
Read now
Read now
Francesco Trotta, Fabrizio Caldera, Roberta Cavalli, Marco Soster, Chiara Riedo, Miriam Biasizzo, Gloria Uccello Barretta, Federica Balzano & Valentina Brunella. (2016) Molecularly imprinted cyclodextrin nanosponges for the controlled delivery of L-DOPA: perspectives for the treatment of Parkinson’s disease. Expert Opinion on Drug Delivery 13:12, pages 1671-1680.
Read now
Read now
Peter Hinow, Ami Radunskaya, Sean M. Mackay, John N. J. Reynolds, Morgan Schroeder, Eng Wui Tan & Ian G. Tucker. (2016) Signaled drug delivery and transport across the blood–brain barrier. Journal of Liposome Research 26:3, pages 233-245.
Read now
Read now
Rebecca L McCall, Joseph Cacaccio, Eileen Wrabel, Mary E Schwartz, Timothy P Coleman & Rachael W Sirianni. (2014) Pathogen-inspired drug delivery to the central nervous system. Tissue Barriers 2:4.
Read now
Read now
Articles from other publishers (54)
Mohammad Amin Rajizadeh, Sina Motamedy, Yousof Mir, Faezeh Akhgarandouz, Mohammad Hadi Nematollahi & Akram Nezhadi. (2023) A comprehensive and updated review on the applications of vesicular drug delivery systems in treatment of brain disorders: A shelter against storms. Journal of Drug Delivery Science and Technology 89, pages 105011.
Crossref
Crossref
Rubina Roy, Rajib Paul, Pallab Bhattacharya & Anupom Borah. (2023) Combating Dopaminergic Neurodegeneration in Parkinson’s Disease through Nanovesicle Technology. ACS Chemical Neuroscience 14:16, pages 2830-2848.
Crossref
Crossref
Emile F. van Vliet, Maarten J. Knol, Raymond M. Schiffelers, Massimiliano Caiazzo & Marcel H.A.M. Fens. (2023) Levodopa-loaded nanoparticles for the treatment of Parkinson's disease. Journal of Controlled Release 360, pages 212-224.
Crossref
Crossref
Elena Allegritti, Sara Battista, Maria Anna Maggi, Claudia Marconi, Luciano Galantini & Luisa Giansanti. (2023) Novel liposomal formulations for protection and delivery of levodopa: Structure-properties correlation. International Journal of Pharmaceutics 643, pages 123230.
Crossref
Crossref
Subham Preetam, Swathi Jonnalagadda, Lamha Kumar, Rajeswari Rath, Soham Chattopadhyay, Badrah S. Alghamdi, Adel M Abuzenadah, Niraj Kumar Jha, Akash Gautam, Sumira Malik & Ghulam Md Ashraf. (2023) Therapeutic potential of lipid nanosystems for the treatment of Parkinson’s disease. Ageing Research Reviews 89, pages 101965.
Crossref
Crossref
Taahirah Boltman, Mervin Meyer & Okobi Ekpo. (2023) Diagnostic and Therapeutic Approaches for Glioblastoma and Neuroblastoma Cancers Using Chlorotoxin Nanoparticles. Cancers 15:13, pages 3388.
Crossref
Crossref
Sara Hernando, Edorta Santos‐Vizcaíno, Manoli Igartua & Rosa Maria Hernandez. (2023) Targeting the central nervous system: From synthetic nanoparticles to extracellular vesicles—Focus on Alzheimer's and Parkinson's disease. WIREs Nanomedicine and Nanobiotechnology.
Crossref
Crossref
Sumel Ashique, Obaid Afzal, Sabina Yasmin, Afzal Hussain, Mohammad A. Altamimi, Thomas J Webster & Abdulmalik S.A. Altamimi. (2023) Strategic nanocarriers to control neurodegenerative disorders: Concept, challenges, and future perspective. International Journal of Pharmaceutics 633, pages 122614.
Crossref
Crossref
Zi-Hua Guo, Saadullah Khattak, Mohd Ahmar Rauf, Mohammad Azam Ansari, Mohammad N. Alomary, Sufyan Razak, Chang-Yong Yang, Dong-Dong Wu & Xin-Ying Ji. (2023) Role of Nanomedicine-Based Therapeutics in the Treatment of CNS Disorders. Molecules 28:3, pages 1283.
Crossref
Crossref
Anjali Bhosale, Gajanan Paul, Farhan Mazahir & A.K. Yadav. (2023) Theoretical and applied concepts of nanocarriers for the treatment of Parkinson's diseases. OpenNano 9, pages 100111.
Crossref
Crossref
Ece Guler, Elif Beyzanur Polat & Muhammet Emin Cam. 2023. Biomaterials for Neural Tissue Engineering. Biomaterials for Neural Tissue Engineering
221
268
.
Nishit Pathak, Sunil K. Vimal, Cao Hongyi & Sanjib Bhattacharya. 2022. Targeted Drug Delivery. Targeted Drug Delivery
389
424
.
Priyanka Saha, Subhankar Bose, Md Noushad Javed & Amit K. Srivastava. 2022. Advances in Nanotechnology-Based Drug Delivery Systems. Advances in Nanotechnology-Based Drug Delivery Systems
133
154
.
Rahul Shukla, Vaibhavi Srivastava, Aakriti Sethi & Munindra Ruwali. 2022. Nanomedical Drug Delivery for Neurodegenerative Diseases. Nanomedical Drug Delivery for Neurodegenerative Diseases
243
259
.
Milad Roshani, Nasim Kiaie & Rouhollah Mehdinavaz Aghdam. (2021) Biomaterials and stem cells as drug/gene-delivery vehicles for Parkinson's treatment: an update. Regenerative Medicine 16:12, pages 1057-1072.
Crossref
Crossref
Claudia Riccardi, Filomena Napolitano, Daniela Montesarchio, Simone Sampaolo & Mariarosa Anna Beatrice Melone. (2021) Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases. Pharmaceutics 13:11, pages 1897.
Crossref
Crossref
Tianqi Nie, Zhiyu He, Jinchang Zhu, Kuntao Chen, Gregory P. Howard, Jesus Pacheco-Torres, Il Minn, Pengfei Zhao, Zaver M. Bhujwalla, Hai-Quan Mao, Lixin Liu & Yongming Chen. (2021) Non-invasive delivery of levodopa-loaded nanoparticles to the brain via lymphatic vasculature to enhance treatment of Parkinson’s disease. Nano Research 14:8, pages 2749-2761.
Crossref
Crossref
Uma Maheswari Krishnan. (2021) Biomaterials in the treatment of Parkinson's disease. Neurochemistry International 145, pages 105003.
Crossref
Crossref
Parisa Gazerani. (2021) Venoms as an adjunctive therapy for Parkinson’s disease: where are we now and where are we going?. Future Science OA 7:2.
Crossref
Crossref
Trisha Bhatt, Bhoomika M. Patel & Mayur M. Patel. 2021. Drug Delivery Devices and Therapeutic Systems. Drug Delivery Devices and Therapeutic Systems
491
513
.
Maria Bohra, Ankan Sarkar, Swapnil Raut, Upasna Singh, Priya Jagtap, Birva Shah, Falguni Baidya, Aishika Datta, Harpreet Kaur, Deepaneeta Sarmah, Anupom Borah, Kunjan R. Dave & Pallab Bhattacharya. 2021. Advances in Polymeric Nanomaterials for Biomedical Applications. Advances in Polymeric Nanomaterials for Biomedical Applications
291
307
.
Hafsa Ahmad, Abhishek Arya, Satish Agrawal & Anil Kumar Dwivedi. 2021. Nanopharmaceuticals: Principles and Applications Vol. 1. Nanopharmaceuticals: Principles and Applications Vol. 1
1
71
.
Bhumika Kumar, Mukesh Pandey, Faheem H. Pottoo, Faizana Fayaz, Anjali Sharma & P.K. Sahoo. (2020) Liposomes: Novel Drug Delivery Approach for Targeting Parkinson’s Disease. Current Pharmaceutical Design 26:37, pages 4721-4737.
Crossref
Crossref
Zahra Ebrahimi, Sam Talaei, Shahin Aghamiri, Nasser Hashemi Goradel, Ali Jafarpour & Babak Negahdari. (2020) Overcoming the blood–brain barrier in neurodegenerative disorders and brain tumours. IET Nanobiotechnology 14:6, pages 441-448.
Crossref
Crossref
Ankita Paul & Khushwant S. Yadav. (2020) Parkinson's disease: Current drug therapy and unraveling the prospects of nanoparticles. Journal of Drug Delivery Science and Technology 58, pages 101790.
Crossref
Crossref
M.I. Teixeira, C.M. Lopes, M.H. Amaral & P.C. Costa. (2020) Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases. European Journal of Pharmaceutics and Biopharmaceutics 149, pages 192-217.
Crossref
Crossref
Peng Mi, Horacio Cabral & Kazunori Kataoka. (2019) Ligand‐Installed Nanocarriers toward Precision Therapy. Advanced Materials 32:13, pages 1902604.
Crossref
Crossref
Fereshteh Bayat, Reza Hosseinpour-Moghadam, Fatemeh Mehryab, Yousef Fatahi, Niayesh Shakeri, Rassoul Dinarvand, Timo L.M. Ten Hagen & Azadeh Haeri. (2020) Potential application of liposomal nanodevices for non-cancer diseases: an update on design, characterization and biopharmaceutical evaluation. Advances in Colloid and Interface Science 277, pages 102121.
Crossref
Crossref
Govindarajan Karthivashan, Palanivel Ganesan, Shin-Young Park, Ho-Won Lee & Dong-Kug Choi. (2020) Lipid-based nanodelivery approaches for dopamine-replacement therapies in Parkinson's disease: From preclinical to translational studies. Biomaterials 232, pages 119704.
Crossref
Crossref
Dinglin Zhang & Jianxiang Zhang. (2020) Surface engineering of nanomaterials with phospholipid-polyethylene glycol-derived functional conjugates for molecular imaging and targeted therapy. Biomaterials 230, pages 119646.
Crossref
Crossref
Yan Luo, Hang Yang, Yi-Fan Zhou & Bo Hu. (2020) Dual and multi-targeted nanoparticles for site-specific brain drug delivery. Journal of Controlled Release 317, pages 195-215.
Crossref
Crossref
Nina Filipczak, Jiayi Pan, Satya Siva Kishan Yalamarty & Vladimir P. Torchilin. (2020) Recent advancements in liposome technology. Advanced Drug Delivery Reviews 156, pages 4-22.
Crossref
Crossref
Magisetty Obulesu. 2020. Parkinson's Disease Therapeutics. Parkinson's Disease Therapeutics
75
88
.
Henrique de Oliveira Amaral, Victoria Monge-Fuentes, Andréia Biolchi Mayer, Gabriel Avohay Alves Campos, Kamila Soares Lopes, Luana C. Camargo, Matheus Ferroni Schwartz, Priscilla Galante & Márcia R. Mortari. (2019) Animal venoms: therapeutic tools for tackling Parkinson’s disease. Drug Discovery Today 24:11, pages 2202-2211.
Crossref
Crossref
Xiaoqian Niu, Jiejian Chen & Jianqing Gao. (2019) Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: Focus on recent advances. Asian Journal of Pharmaceutical Sciences 14:5, pages 480-496.
Crossref
Crossref
Asya Ozkizilcik, Aruna Sharma, José Vicente Lafuente, Dafin F. Muresanu, Ala Nozari, Z. Ryan Tian, Herbert Mössler & Hari Shanker Sharma. 2019. Nanoneuroprotection and Nanoneurotoxicology. Nanoneuroprotection and Nanoneurotoxicology
201
246
.
Josef Jampílek, Katarína Kráľová, Petr Novák & Michal Novák. 2019. Nanobiotechnology in Neurodegenerative Diseases. Nanobiotechnology in Neurodegenerative Diseases
65
138
.
You Jung Kang, Eric Gerard Cutler & Hansang Cho. (2018) Therapeutic nanoplatforms and delivery strategies for neurological disorders. Nano Convergence 5:1.
Crossref
Crossref
Yan Li, Ruiyuan Liu, Weihong Ji, Yanhui Li, Linying Liu & Xin Zhang. (2018) Delivery systems for theranostics in neurodegenerative diseases. Nano Research 11:10, pages 5535-5555.
Crossref
Crossref
Débora Braga Vieira & Lionel Fernel Gamarra. 2018. Molecular Insight of Drug Design. Molecular Insight of Drug Design.
William Langhoff, Alexander Riggs & Peter Hinow. (2018) Scaling behavior of drug transport and absorption in in silico cerebral capillary networks. PLOS ONE 13:7, pages e0200266.
Crossref
Crossref
Yung-Chih Kuo & Rajendiran Rajesh. (2018) Current development of nanocarrier delivery systems for Parkinson's disease pharmacotherapy. Journal of the Taiwan Institute of Chemical Engineers 87, pages 15-25.
Crossref
Crossref
Rita Nieto Montesinos. 2017. Liposomes. Liposomes.
Paola G. Ojeda, Sónia Troeira Henriques, Yijun Pan, Joseph A. Nicolazzo, David J. Craik & Conan K. Wang. (2017) Lysine to arginine mutagenesis of chlorotoxin enhances its cellular uptake. Peptide Science 108:5.
Crossref
Crossref
Daniela Silva Adaya, Lucinda Aguirre-Cruz, Jorge Guevara & Emma Ortiz-Islas. (2016) Nanobiomaterials’ applications in neurodegenerative diseases. Journal of Biomaterials Applications 31:7, pages 953-984.
Crossref
Crossref
Or Cohen-Inbar & Menashe Zaaroor. (2016) Glioblastoma multiforme targeted therapy: The Chlorotoxin story. Journal of Clinical Neuroscience 33, pages 52-58.
Crossref
Crossref
Diana Dehaini, Ronnie H. Fang & Liangfang Zhang. (2016) Biomimetic strategies for targeted nanoparticle delivery. Bioengineering & Translational Medicine 1:1, pages 30-46.
Crossref
Crossref
A.M. Cardoso, J.R. Guedes, A.L. Cardoso, C. Morais, P. Cunha, A.T. Viegas, R. Costa, A. Jurado & M.C. Pedroso de Lima. 2016. Nanotechnology and the Brain. Nanotechnology and the Brain
1
40
.
Paola G. Ojeda, Conan K. Wang & David J. Craik. (2016) Chlorotoxin: Structure, activity, and potential uses in cancer therapy. Biopolymers 106:1, pages 25-36.
Crossref
Crossref
Elena Soddu, Giovanna Rassu, Paolo Giunchedi, Bruno Sarmento & Elisabetta Gavini. (2015) From naturally-occurring neurotoxic agents to CNS shuttles for drug delivery. European Journal of Pharmaceutical Sciences 74, pages 63-76.
Crossref
Crossref
Xueqing Wang, Suxin Li, Yujie Shi, Xingxing Chuan, Ji Li, Ting Zhong, Hua Zhang, Wenbing Dai, Bing He & Qiang Zhang. (2014) The development of site-specific drug delivery nanocarriers based on receptor mediation. Journal of Controlled Release 193, pages 139-153.
Crossref
Crossref
Sibel Bozdağ Pehlivan. (2013) Nanotechnology-Based Drug Delivery Systems for Targeting, Imaging and Diagnosis of Neurodegenerative Diseases. Pharmaceutical Research 30:10, pages 2499-2511.
Crossref
Crossref
BenNasr Hmed, Hammami Turky Serria & Zeghal Khaled Mounir. (2013) Scorpion Peptides: Potential Use for New Drug Development. Journal of Toxicology 2013, pages 1-15.
Crossref
Crossref
Mayank Gangwar, Ragini Singh, RK Goel & Gopal Nath. (2012) Recent advances in various emerging vescicular systems: An overview. Asian Pacific Journal of Tropical Biomedicine 2:2, pages S1176-S1188.
Crossref
Crossref